Mortality and morbidity in transsexual patients with cross-gender hormone treatment
about
The effect of cross-sex hormonal treatment on gender dysphoria individuals' mental health: a systematic reviewClinical management of transsexual subjectsTransgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practicesGonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.A review of the physical and metabolic effects of cross-sex hormonal therapy in the treatment of gender dysphoria.Long-term cross-sex hormone treatment is safe in transsexual subjects.Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses.Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals.Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review.Cross-sex hormone therapy for gender dysphoria.Cancer in Transgender People: Evidence and Methodological Considerations.Oestrogen and anti-androgen therapy for transgender women.Prolactin levels during short- and long-term cross-sex hormone treatment: an observational study in transgender persons.Long-term follow-up of individuals undergoing sex reassignment surgery: Psychiatric morbidity and mortality.Mental Health of Transgender People in Hong Kong: A Community-Driven, Large-Scale Quantitative Study Documenting Demographics and Correlates of Quality of Life and Suicidality.Male-to-female transsexual surgery: experience at the UFRJ University Hospital.Nutritional Status and Obesity Prevalence in People with Gender Dysphoria.Low estrogen doses normalize testosterone and estradiol levels to the female range in transgender women.Health and Cardiometabolic Disease in Transgender Adults in the United States: Behavioral Risk Factor Surveillance System 2015.
P2860
Q26740930-6D50F004-80C9-4786-92D8-4CC0B53D2DE7Q26823448-5975D4EE-5812-4329-AD53-46D2D0B6F10EQ28067469-9462F9AB-D5DE-462A-BB0C-0F89D24BB2C7Q34438584-9CB99F17-F44F-477D-97D8-F9560F02688CQ34474654-EB15FAD0-9383-42C0-A80C-F773C7A1215CQ37037619-D74FEAD6-666F-40DE-BEEC-21A85F967224Q37497438-BEC2CB1A-3F08-463B-8B08-068537865D43Q37579816-AED17387-9A1B-4413-9FAB-B47C49D611FEQ38128907-D5AEC896-7D10-42DC-BE6F-24A201C92F0BQ38268810-B0E401D0-4298-4E28-A2D8-10FE7EC5CA0CQ38685944-D2F66729-8D64-48F7-94AA-D3AC62239ECCQ38787403-D225DF42-CE5D-45C4-B0A0-42AB0F63A8CFQ39453462-F63DE433-0E5D-488A-856C-11E41BEAAD17Q40417048-28FE0E7A-4BD0-43C0-ACE2-1A25179BD1B4Q47279682-3E5686C4-AB6B-40D3-A503-EB1B381B5DE0Q51054576-4B1C97EB-A68A-40C8-AE9B-F8D05B58978AQ55194780-0492B60C-124E-48DD-975B-1E632868DFCFQ55379893-99F9DBEF-0C77-44C5-9B81-4789B28FF9BDQ55451293-6643626F-A497-4D19-9277-A92DA9AF6EA0
P2860
Mortality and morbidity in transsexual patients with cross-gender hormone treatment
description
1989 nî lūn-bûn
@nan
1989 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Mortality and morbidity in transsexual patients with cross-gender hormone treatment
@ast
Mortality and morbidity in transsexual patients with cross-gender hormone treatment
@en
Mortality and morbidity in transsexual patients with cross-gender hormone treatment
@nl
type
label
Mortality and morbidity in transsexual patients with cross-gender hormone treatment
@ast
Mortality and morbidity in transsexual patients with cross-gender hormone treatment
@en
Mortality and morbidity in transsexual patients with cross-gender hormone treatment
@nl
prefLabel
Mortality and morbidity in transsexual patients with cross-gender hormone treatment
@ast
Mortality and morbidity in transsexual patients with cross-gender hormone treatment
@en
Mortality and morbidity in transsexual patients with cross-gender hormone treatment
@nl
P2093
P3181
P1433
P1476
Mortality and morbidity in transsexual patients with cross-gender hormone treatment
@en
P2093
H Asscheman
L J Gooren
P L Eklund
P304
P3181
P356
10.1016/0026-0495(89)90233-3
P407
P577
1989-09-01T00:00:00Z